DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
17.28
-0.11 (-0.63%)
Jun 6, 2025, 3:00 PM CST
SHA:603233 Market Cap
SHA:603233 has a market cap or net worth of 19.68 billion as of June 6, 2025. Its market cap has decreased by -24.41% in one year.
Market Cap
19.68B
Enterprise Value
21.05B
Revenue
26.70B
Ranking
n/a
PE Ratio
20.04
Stock Price
17.28
Market Cap Chart
Since July 31, 2017, SHA:603233's market cap has increased from 14.24B to 19.68B, an increase of 38.19%. That is a compound annual growth rate of 4.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 356.93B |
Shenzhen Mindray Bio-Medical Electronics | 284.57B |
WuXi AppTec | 184.51B |
Zhangzhou Pientzehuang Pharmaceutical., | 122.65B |
Sichuan Biokin Pharmaceutical | 122.55B |
Aier Eye Hospital Group | 117.29B |
Shanghai United Imaging Healthcare | 116.46B |
Yunnan Baiyao Group Co.,Ltd | 100.54B |